Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lipigon Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11221
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lipigon Pharmaceuticals AB (Lipigon Pharmaceuticals) is a lipid biology company that discovers and develops novel therapies for lipid disorders and other cardiometabolic risk factors. The company offers developing its products in various therapeutic areas such as cardiovascular and metabolic disorders. It discovers small molecule activators of lipoprotein lipase. Lipigon Pharmaceuticals’ lead product candidate is designed to significantly lower the elevated levels of TG, raise levels of HDL and improve other cardiometabolic risk factors. The company partners with other pharmaceutical companies to develop new projects. Lipigon Pharmaceuticals is headquartered in Umea, Sweden.

Lipigon Pharmaceuticals AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB – Key Competitors 13
Lipigon Pharmaceuticals AB – Key Employees 14
Lipigon Pharmaceuticals AB – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Apr 06, 2017: Lipigon Pharmaceuticals announces new appointed members of the board – Gisela Sitbon and Erik Lund 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Key Facts 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB, Key Competitors 13
Lipigon Pharmaceuticals AB, Key Employees 14

List of Figures
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lonestar Resources US Inc (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Neptune Orient Lines Limited:企業の戦略・SWOT・財務情報
    Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report Summary Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CEMEX, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    CEMEX, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary CEMEX, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Molnlycke Health Care AB:企業の戦略的SWOT分析
    Molnlycke Health Care AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Oramed Pharmaceuticals Inc (ORMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique …
  • Cognition Financial Corporation:企業の戦略・SWOT・財務情報
    Cognition Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognition Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Zest Dental Solutions:医療機器:M&Aディール及び事業提携情報
    Summary Zest Dental Solutions (Zest Dental), formerly ZEST Anchors LLC is a medical device manufacturing company that manufactures, develops, and distributes dental solutions for the treatment of edentulous patients. The company’s products include dental removal tool, attachment processing materials …
  • Townsquare Media, Inc.:企業のM&A・事業提携・投資動向
    Townsquare Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Townsquare Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • International Finance Corp:企業の戦略的SWOT分析
    International Finance Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Detroit Medical Center:企業の戦略的SWOT分析
    Detroit Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Mylan NV (MYL):医療機器:M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …
  • Banque Cramer & Cie SA:企業の戦略・SWOT・財務情報
    Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report Summary Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Eneco Holding NV-エネルギー分野:企業M&A・提携分析
    Summary Eneco Holding N.V. (Eneco) is an integrated energy company. It produces, trades, transmits and supplies gas, electricity and heat. Eneco undertakes the sale, rental, installation, and maintenance of heating and hot water equipment; and maintenance of the electricity, gas and district heat ne …
  • Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. Its pipeline products include Leronlimab (PRO 140), a ful …
  • Flowserve Corporation:企業の戦略・SWOT・財務分析
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Bank Of East Asia, Limited
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Credit Suisse Group AG:戦略・SWOT・企業財務分析
    Credit Suisse Group AG - Strategy, SWOT and Corporate Finance Report Summary Credit Suisse Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Petroleum Development Oman LLC:企業の戦略的SWOT分析
    Petroleum Development Oman LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Northern Oil & Gas Inc (NOG):企業の財務・戦略的SWOT分析
    Summary Northern Oil & Gas Inc (Northern) is an oil and gas company that offers acquisition, exploration and production services. The company acquires and maintains oil and natural gas properties in Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. It offers s …
  • Proteus Digital Health Inc:企業の戦略的SWOT分析
    Proteus Digital Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆